Status:
COMPLETED
Prevention of Cervical Cancer Through an HPV-based Screen-and-treat Strategy in Malawi
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborating Sponsors:
United States Agency for International Development (USAID)
Conditions:
Cervical Cancer
Eligibility:
FEMALE
15-50 years
Phase:
NA
Brief Summary
The purpose of the study is to determine the acceptability, appropriateness, and feasibility of implementing new strategies to screen and treat eligible women for cervical cancer through a cluster ran...
Detailed Description
Cervical cancer is largely preventable through screening and preventive therapy. This is a cluster randomized trial that will integrate a novel cervical cancer screen-and-treat algorithm into voluntar...
Eligibility Criteria
Inclusion
- Health care providers In-Depth Interviews (IDIs) and Focus Group Discussions:
- Health care staff member must be currently working at one of the 16 health facilities selected for the study.
- Client In-Depth Interviews:
- Woman must have participated in cervical cancer screening via HPV self-sampling through one of the 16 health facilities during the study period.
- Client Exit Surveys:
- Woman who received or declined VFP and/or CCS services in the catchment area of the targeted facilities.
- Endline Household survey:
- Woman must be between the ages of 15-50 years.
Exclusion
- Endline Household survey:
- Woman who has had her cervix removed.
Key Trial Info
Start Date :
March 4 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 18 2021
Estimated Enrollment :
8174 Patients enrolled
Trial Details
Trial ID
NCT04286243
Start Date
March 4 2020
End Date
December 18 2021
Last Update
November 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UNC Project-Malawi
Lilongwe, Malawi